𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer

✍ Scribed by Barry H. Trachtenberg; David C. Landy; Vivian I. Franco; Jacqueline M. Henkel; Elliot J. Pearson; Tracie L. Miller; Steven E. Lipshultz

Book ID
105938804
Publisher
Springer
Year
2011
Tongue
English
Weight
447 KB
Volume
32
Category
Article
ISSN
0172-0643

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Late anthracycline cardiotoxicity after
Late anthracycline cardiotoxicity after childhood cancer : A prospective longitudinal study
✍ Keld Sorensen; Gill A. Levitt; Catherine Bull; Inge Dorup; Ian D. Sullivan πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## BACKGROUND The objective of the current study was to examine the risk factors for progression in severity of anthracycline‐induced cardiac dysfunction, thereby providing information that is useful in refining cancer treatment regimes and guiding follow‐up. ## METHODS Serial echoca

Late cardiotoxicity after bolus versus i
Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers
✍ Gupta, Monesha ;Steinherz, Peter G. ;Cheung, Nai-Kong ;Steinherz, Laurel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 72 KB

## Abstract ## Objective To compare the long‐term myocardial function of patients who had been treated with infusion anthracycline therapy (administered continuously over >24 hr, IG) versus bolus therapy (administered over <30 min, BG). ## Methods We selected 25 patients (BG) and 19 patients (IG